Randomized Control Trials
Apixaban 2.5 mg BID to prevent VTE after elective TKR surgeries: Superior efficacy without increased bleeding vs. subcutaneous enoxaparin 40 mg QD2
Mean duration of treatment was 12.1±3.2 days for Apixaban and 12.1±2.8 days for enoxaparin. 2
*p values are one sided for superiority test of relative risk. 2
Apixaban 2.5 mg BID to prevent VTE after elective THR surgeries: Superior efficacy vs enoxaparin 40 mg QD with no significant increased risk of major bleeding3
The mean duration of treatment was 34.0±7.7 days in the Apixaban group and 33.9±7.8 days in the enoxaparin group.3
*p values are two-sided for superiority test of relative risk. 3
ADVANCE-2: Apixaban versus Enoxaparin for Thromboprophylaxis after Knee Replacement; BID: twice daily; DVT: deep- vein thrombosis; PE: pulmonary embolism; RRR: relative risk reduction; QD: once daily; SC: subcutaneous; TKR: total knee replacement; THR: total hip replacement; VTE: venous thromboembolism.
References: 1 Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981-992. 2. Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Hornick P; ADVANCE-2 investigators. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomized double-blind trial. Lancet. 2010;375(9717):807-815. 3. Lassen MR, Gallus A, Raskob GE, Pineo G, Chen D, Ramirez LM; ADVANCE-3 Investigators. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med. 2010;363(26):2487-2498.
#Ruff CT, et al. Lancet. 2014;383(9921):955-62, Hur et al, Acta Orthopaedica 2017; 88 (6): 634–641, Cohen AT et al. Adv Ther 2014;31:473-93
Disclaimer: The products discussed herein may have different product labeling in different countries. The product information provided in this site is intended only for residents of India
Please click on Prescribing Information link to view safety and adverse events information of Eliquis
For the use only of registered medical practitioner, or a hospital or a laboratory.